Solara Active Pharma Sciences reports consolidated net loss of Rs 275.34 crore in the December 2023 quarter
Sales decline 36.99% to Rs 248.73 crore
Net loss of Solara Active Pharma Sciences reported to Rs 275.34 crore in the quarter ended December 2023 as against net profit of Rs 0.45 crore during the previous quarter ended December 2022. Sales declined 36.99% to Rs 248.73 crore in the quarter ended December 2023 as against Rs 394.75 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales248.73394.75 -37 OPM %-65.0111.40 -PBDT-186.6128.53 PL PBT-212.570.55 PL NP-275.340.45 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 15 2024 | 4:20 PM IST